These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27003157)

  • 1. Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
    Ricardo S; Marcos-Silva L; Valente C; Coelho R; Gomes R; David L
    Virchows Arch; 2016 Jun; 468(6):715-22. PubMed ID: 27003157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
    Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
    Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
    Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
    Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucins and Truncated
    Coelho R; Marcos-Silva L; Mendes N; Pereira D; Brito C; Jacob F; Steentoft C; Mandel U; Clausen H; David L; Ricardo S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
    Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
    Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
    Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
    J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer.
    Jain S; Nadeem N; Ulfenborg B; Mäkelä M; Ruma SA; Terävä J; Huhtinen K; Leivo J; Kristjansdottir B; Pettersson K; Sundfeldt K; Gidwani K
    Int J Cancer; 2022 Oct; 151(7):1175-1184. PubMed ID: 35531590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.
    Dharmaraj N; Chapela PJ; Morgado M; Hawkins SM; Lessey BA; Young SL; Carson DD
    Hum Reprod; 2014 Aug; 29(8):1730-8. PubMed ID: 24939955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.
    Williams KA; Terry KL; Tworoger SS; Vitonis AF; Titus LJ; Cramer DW
    PLoS One; 2014; 9(2):e88334. PubMed ID: 24551091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
    Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
    Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
    PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Qian X; Xi X; Li L
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
    Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
    J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.
    Shibahara H; Higashi M; Koriyama C; Yokoyama S; Kitazono I; Kurumiya Y; Narita M; Kuze S; Kyokane T; Mita S; Arai T; Kato T; Yuasa N; Yamaguchi R; Kubota H; Suzuki H; Baba S; Rousseau K; Batra SK; Yonezawa S
    PLoS One; 2014; 9(4):e86111. PubMed ID: 24722639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.
    Budiu RA; Mantia-Smaldone G; Elishaev E; Chu T; Thaller J; McCabe K; Lenzner D; Edwards RP; Vlad AM
    Cancer Immunol Immunother; 2011 Jul; 60(7):975-84. PubMed ID: 21461842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
    Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
    Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
    BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.